Es gab 50 kürzliche Insider-Transaktionen für Nutra Pharma Corp. (NPHC), darunter 37 Käufe und 11 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $339.06B und die gesamten Insider-Verkäufe auf $444.24K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Deitsch Rik J, Oran Dan, Rumph Harold Henry. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — NPHC
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2021-11-15 |
Deitsch Rik J |
President, CEO |
Veräußerung |
- |
- |
- |
43,298,859 |
| 2017-10-30 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
RSU-Zuteilung |
3,000,000 |
- |
- |
3,000,000 |
| 2016-12-19 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
Informierter Kauf |
15,000,000 |
$0.01 |
$75K |
43,298,859 |
| 2016-07-05 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
Informierter Kauf |
15,000,000 |
$0.01 |
$100.5K |
28,298,859 |
| 2016-06-28 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
RSU-Zuteilung |
4,000,000 |
$0.01 |
$54K |
13,298,859 |
| 2016-06-17 |
Oran Dan |
Director |
Unbekannt |
- |
- |
- |
200,000 |
| 2015-06-13 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
RSU-Zuteilung |
4,000,000 |
$0.19 |
$740K |
9,298,859 |
| 2014-12-11 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
RSU-Zuteilung |
506,900 |
$0.24 |
$121.66K |
5,298,859 |
| 2014-04-10 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
Informierter Kauf |
1,250,000 |
$0.08 |
$100K |
4,791,959 |
| 2013-11-25 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
RSU-Zuteilung |
11,760,000 |
$0.01 |
$164.64K |
141,678,334 |
| 2013-11-25 |
Rumph Harold Henry |
President - Receptopharm |
RSU-Zuteilung |
7,400,000 |
$0.01 |
$103.6K |
35,000,000 |
| 2013-11-25 |
Pottruck Garry |
Director |
RSU-Zuteilung |
6,890,000 |
$0.01 |
$96.46K |
17,815,000 |
| 2013-10-18 |
Lonky Stewart Alan |
Director |
Aktienrückgabe |
70,000 |
$0.01 |
$560.00 |
20,220,000 |
| 2013-09-09 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
Informierter Kauf |
25,000,000 |
$0.00 |
$62.5K |
129,918,334 |
| 2013-09-09 |
Rumph Harold Henry |
President - Receptopharm |
Informierter Kauf |
14,800,000 |
$0.00 |
$37K |
27,600,000 |
| 2013-06-27 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
Informierter Kauf |
25,000,000 |
$0.00 |
$100K |
104,918,334 |
| 2013-03-08 |
Lonky Stewart Alan |
Director |
RSU-Zuteilung |
7,730,000 |
$0.01 |
$77.3K |
20,150,000 |
| 2012-12-19 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
Informierter Kauf |
10,000,000 |
$0.01 |
$100K |
79,918,334 |
| 2012-12-10 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
Informierter Kauf |
200,000 |
$0.01 |
$2.98K |
69,918,334 |
| 2012-10-18 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
RSU-Zuteilung |
7,500,000 |
$0.02 |
$165K |
69,718,334 |
| 2012-10-18 |
Rumph Harold Henry |
President - Receptopharm |
RSU-Zuteilung |
5,000,000 |
$0.02 |
$110K |
12,800,000 |
| 2012-10-18 |
Pottruck Garry |
Director |
RSU-Zuteilung |
5,500,000 |
$0.02 |
$121K |
10,925,000 |
| 2012-10-18 |
Lonky Stewart Alan |
Director |
RSU-Zuteilung |
5,000,000 |
- |
- |
12,420,000 |
| 2012-08-30 |
Sartori Bruno |
Officer |
Informierter Verkauf |
303,990 |
$0.01 |
$3.34K |
240,000 |
| 2012-06-01 |
Sartori Bruno |
Officer |
Informierter Kauf |
8,100 |
$0.01 |
$105.30 |
486,100 |
| 2012-05-31 |
Sartori Bruno |
Officer |
Informierter Kauf |
10,000 |
$0.01 |
$130.00 |
478,000 |
| 2012-05-30 |
Sartori Bruno |
Officer |
Informierter Kauf |
8,000 |
$0.02 |
$120.00 |
468,000 |
| 2012-05-22 |
Sartori Bruno |
Officer |
Informierter Kauf |
7,000 |
$0.01 |
$77.00 |
460,000 |
| 2012-04-26 |
Sartori Bruno |
Officer |
Informierter Kauf |
105,000 |
$0.01 |
$1.16K |
453,000 |
| 2012-04-25 |
Sartori Bruno |
Officer |
Informierter Kauf |
68,000 |
$0.01 |
$782.00 |
348,000 |
| 2012-04-24 |
Sartori Bruno |
Officer |
Informierter Kauf |
10,000 |
$0.01 |
$135.00 |
280,000 |
| 2012-04-23 |
Sartori Bruno |
Officer |
Informierter Kauf |
5,000 |
$0.01 |
$62.50 |
245,000 |
| 2012-04-23 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
Informierter Kauf |
148,000 |
$1,741.88 |
$257.8M |
62,218,334 |
| 2012-02-10 |
Sartori Bruno |
Officer |
RSU-Zuteilung |
240,000 |
- |
- |
240,000 |
| 2012-02-10 |
Rumph Harold Henry |
President - Receptopharm |
RSU-Zuteilung |
4,000,000 |
$0.02 |
$66K |
7,800,000 |
| 2012-02-10 |
Pottruck Garry |
Director |
RSU-Zuteilung |
2,875,000 |
$0.02 |
$47.44K |
5,425,000 |
| 2012-02-10 |
Deitsch Rik J |
10 Percent Owner, Officer: President, CEO |
RSU-Zuteilung |
6,800,000 |
$0.02 |
$119K |
62,070,334 |
| 2012-02-10 |
Lonky Stewart Alan |
Director |
RSU-Zuteilung |
4,400,000 |
$77,000.00 |
$338.8B |
7,420,000 |
| 2011-01-20 |
Lonky Stewart Alan |
Director |
Informierter Kauf |
10,000 |
$0.13 |
$1.3K |
3,020,000 |
| 2010-12-31 |
Isserman David Michael |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2010-12-21 |
Lonky Stewart Alan |
Director |
Informierter Kauf |
10,000 |
$0.08 |
$800.00 |
3,010,000 |
| 2010-04-09 |
Rumph Harold Henry |
President - Receptopharm |
Informierter Verkauf |
400,000 |
$0.39 |
$156K |
3,800,000 |
| 2010-02-17 |
Rumph Harold Henry |
Director |
Informierter Verkauf |
50,000 |
$0.46 |
$23K |
4,200,000 |
| 2010-02-12 |
Rumph Harold Henry |
Director |
Informierter Verkauf |
50,000 |
$0.40 |
$20K |
4,250,000 |
| 2010-02-11 |
Isserman David Michael |
Chief Marketing Officer |
Veräußerung |
200,000 |
$0.10 |
$20K |
- |
| 2010-02-03 |
Rumph Harold Henry |
Director |
Informierter Verkauf |
50,000 |
$0.37 |
$18.5K |
4,300,000 |
| 2010-01-21 |
Rumph Harold Henry |
Director |
Informierter Verkauf |
50,000 |
$0.33 |
$16.5K |
4,350,000 |
| 2009-11-05 |
Rumph Harold Henry |
Director |
Veräußerung |
- |
- |
- |
4,400,000 |
| 2009-07-29 |
Pottruck Garry |
Director |
Veräußerung |
- |
- |
- |
50,000 |
| 2009-06-18 |
Reid Paul F |
Director |
RSU-Rückgabe |
7,000,000 |
$0.03 |
$186.9K |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall